Related Experiment Video

Updated: Jun 10, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Linking model systems to cancer therapeutics: the case of Mastermind

Barry Yedvobnick1, Ken Moberg

  • 1Department of Biology, Emory University, Atlanta, GA 30322, USA. barry.yedvobnick@emory.edu

Disease Models & Mechanisms
|July 29, 2010
PubMed

Insights

Genetics and genomics highlight conserved cell signaling pathways. Drosophila research offers therapeutic strategies for human diseases, exemplified by targeting Notch signaling in leukemia.

Area of Science:

  • Molecular Biology
  • Genetics
  • Genomics
  • Developmental Biology

Background:

  • Conserved fundamental signaling pathways are revealed through genetics and genomics.
  • Genetic model organisms are increasingly utilized by biomedical scientists for therapeutic research.
  • Drosophila melanogaster serves as a valuable model organism for studying human disease.

Purpose of the Study:

  • To demonstrate the utility of Drosophila in advancing potential therapies for human diseases.
  • To highlight how basic Drosophila genetic information can inform therapeutic strategies.
  • To illustrate the application of Drosophila molecular genetics in developing treatments for human conditions.

Main Methods:

  • Leveraging conserved genetic and genomic information from Drosophila.
  • Applying knowledge of fundamental cell signaling pathways.
  • Utilizing Drosophila molecular genetics techniques.

Main Results:

  • Basic developmental genetic information from Drosophila was used to design a therapeutic intervention.
  • A therapeutic block targeting oncogenic Notch signaling was developed.
  • This therapeutic approach showed relevance to conditions like leukemia in mice.

Conclusions:

  • Drosophila research significantly contributes to understanding and treating human diseases.
  • The study validates the potential of Drosophila molecular genetics in developing novel therapeutic strategies.
  • Targeting conserved signaling pathways, like Notch, in Drosophila can yield human disease therapies.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...